Disease States Associated with Elevated Methylmalonic Acid
Methylmalonic acid is elevated in multiple inborn errors of metabolism affecting propionate and cobalamin pathways, vitamin B12 deficiency, renal dysfunction, and has emerging associations with cardiovascular disease and neurodegenerative conditions.
Primary Metabolic Disorders with Elevated MMA
The following inherited metabolic disorders demonstrate elevated methylmalonic acid according to ACMG guidelines 1:
Classic Methylmalonic Acidemias
- Combined malonic and methylmalonic aciduria (MIM 614265): Characterized by methylmalonic acid elevation (in larger amounts) along with malonic acid 1
- Methylmalonyl-CoA epimerase deficiency (MIM 251120): Presents with ketones, methylmalonic acid, 3-hydroxypropionic acid, methylcitric acid, and propionylglycine 1
- Succinate-CoA ligase deficiencies (SUCLA2 and SUCLG1, MIM 612073 and MIM 612224): Show methylmalonic acid, methylcitric acid, and other metabolites 1
Key Clinical Consideration
The ACMG emphasizes that interpretation should be based on the overall pattern of metabolites rather than isolated MMA elevation, as diagnostic sensitivity varies with the patient's metabolic state (acute versus asymptomatic), residual enzyme activity, dietary precursor load, and anabolic/catabolic status 1.
Vitamin B12 Deficiency
- Functional vitamin B12 deficiency is the most common cause of elevated MMA in clinical practice, as MMA serves as a specific and sensitive marker of B12 deficiency 2, 3
- MMA elevation occurs because vitamin B12 (as adenosylcobalamin) is a required cofactor for methylmalonyl-CoA mutase 4
Age-Related and Cardiovascular Associations
Recent research has identified important associations between elevated MMA and disease states beyond classic metabolic disorders:
Cardiovascular Disease
- Elevated serum MMA levels are independently associated with the presence of cardiovascular diseases (adjusted OR 3.08,95% CI: 1.63-5.81) after controlling for age, gender, ethnicity, smoking, hypertension, glycohemoglobin, BMI, LDL-C, renal dysfunction, and vitamin B12 3
- Higher MMA predicts increased risk of acute myocardial infarction and mortality in patients with established coronary heart disease, with hazard ratios of 1.18-1.30 for various cardiovascular outcomes 5
- The MMA-risk association is stronger in older adults, women, and non-smokers 5
Neurodegenerative Diseases
- Parkinson's disease and dementia: Adult patients with MCEE gene mutations can present with Parkinson's disease, dementia, stroke, and persistently elevated MMA levels 6
- Alzheimer's and Parkinson's disease mortality: Higher MMA levels (Q4 quartile) are associated with 5-6 fold increased mortality in AD (HR 6.39) and PD patients (HR 5.51), suggesting MMA as a biomarker of mitochondrial dysfunction in neurodegeneration 7
- cblC-type methylmalonic acidemia: The most common form in China, characterized by elevated MMA and homocysteine, can cause cognitive impairment 8
Important Clinical Pitfalls
Renal Function Consideration
- MMA levels are influenced by renal function, as kidney dysfunction impairs MMA clearance 3
- Always interpret elevated MMA in the context of creatinine clearance
Age-Related Elevation
- MMA increases with aging independent of disease states, reflecting age-related changes in mitochondrial function and vitamin B12 metabolism 2
- Linear regression models show positive associations between MMA and age 3
Metabolic State Dependency
- In inherited disorders, MMA excretion reflects residual enzyme activity and the patient's current metabolic stress 1
- Some patients may be "low excretors" during asymptomatic periods, potentially missing the diagnosis 1